These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
720 related items for PubMed ID: 10069876
21. One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma. Bensch G, Berger WE, Blokhin BM, Socolovsky AL, Thomson MH, Till MD, Castellsague J, Della Cioppa G, International Study Group on Foradil Evaluation in Pediatric Asthma. Ann Allergy Asthma Immunol; 2002 Aug; 89(2):180-90. PubMed ID: 12197575 [Abstract] [Full Text] [Related]
22. Unaltered perception of dyspnoea during treatment with long-acting beta2-agonists. van der Woude HJ, Aalbers R. Eur Respir J; 2001 Aug; 18(2):269-71. PubMed ID: 11529283 [Abstract] [Full Text] [Related]
23. Proventil HFA and ventolin have similar safety profiles during regular use. Tinkelman DG, Bleecker ER, Ramsdell J, Ekholm BP, Klinger NM, Colice GL, Slade HB. Chest; 1998 Feb; 113(2):290-6. PubMed ID: 9498941 [Abstract] [Full Text] [Related]
24. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients. Palmqvist M, Ibsen T, Mellén A, Lötvall J. Am J Respir Crit Care Med; 1999 Jul; 160(1):244-9. PubMed ID: 10390407 [Abstract] [Full Text] [Related]
26. Formoterol delivered via the dry powder Aerolizer inhaler versus albuterol MDI and placebo in mild-to-moderate asthma: a randomized, double-blind, double-dummy trial. Pleskow W, LaForce CF, Yegen U, Matos D, Della Cioppa G. J Asthma; 2003 Jul; 40(5):505-14. PubMed ID: 14529100 [Abstract] [Full Text] [Related]
32. Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma. Wallin A, Melander B, Rosenhall L, Sandström T, Wåhlander L. Thorax; 1990 Apr; 45(4):259-61. PubMed ID: 1972599 [Abstract] [Full Text] [Related]
35. Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma. Yurdakul AS, Calişir HC, Tunçtan B, Ogretensoy M. Respir Med; 2002 May; 96(5):322-9. PubMed ID: 12113382 [Abstract] [Full Text] [Related]
36. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI. JAMA; 1994 May 11; 271(18):1412-6. PubMed ID: 7909853 [Abstract] [Full Text] [Related]
37. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. Busse W, Levine B, Andriano K, Lavecchia C, Yegen U. Clin Ther; 2004 Oct 11; 26(10):1587-98. PubMed ID: 15598475 [Abstract] [Full Text] [Related]
38. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. Dahl R, Chuchalin A, Gor D, Yoxall S, Sharma R. Respir Med; 2006 Jul 11; 100(7):1152-62. PubMed ID: 16675212 [Abstract] [Full Text] [Related]